EFPIA Urges Adoption of Anticounterfeiting Measure - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

EFPIA Urges Adoption of Anticounterfeiting Measure


ePT--the Electronic Newsletter of Pharmaceutical Technology

Untitled Document

Brussels (May 30)—The European Federation of Pharmaceutical Industries and Associations (EFPIA) called for the pan-European and industry-wide adoption of 2-D barcode technology to combat the increase in counterfeit drugs in Europe.

EFPIA proposed that every medicine pack in Europe have a 2-D data-matrix barcode printed on the packaging. The barcode would be encrypted and have a randomized number that is unique to each pack, making it difficult for counterfeiters to copy the barcodes and introduce counterfeit drugs into the legitimate supply chain. The code could be read by any handheld barcode scanner and would provide a chain of custody wherever it is scanned.

Counterfeit medicines have become a subject of increasing concern in Europe.  The European Commission recently released figures that show a dramatic rise in the number of counterfeit medicines in the legitimate supply chain. The pharmaceutical industry is working to increase public awareness of the problem and come up with a feasible anticounterfeiting solution.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
27%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
32%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: ePT--the Electronic Newsletter of Pharmaceutical Technology,
Click here